Treatment as Required versus Regular Monthly Treatment in the Management of Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis.
<h4>Background</h4>To investigate whether treatment as required 'pro re nata' (PRN) versus regular monthly treatment regimens lead to differences in outcomes in neovascular age-related macular degeneration (nAMD). Regular monthly administration of vascular endothelial growth fa...
Saved in:
| Main Authors: | Christine M Schmucker, Gerta Rücker, Harriet Sommer, Gianni Virgili, Yoon K Loke, Patrick Oeller, Hansjuergen Agostini, Christoph Ehlken |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0137866 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A safety review and meta-analyses of bevacizumab and ranibizumab: off-label versus goldstandard.
by: Christine Schmucker, et al.
Published: (2012-01-01) -
Experience with Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration
by: M. V. Budzinskaya, et al.
Published: (2023-01-01) -
Faricimab for treatment-resistant choroidal neovascularization (CNV) in neovascular age-related macular degeneration (nAMD): seven-months results using artificial intelligence and OCTA
by: Anna Heinke, et al.
Published: (2025-06-01) -
Clinical Evaluation of the Effectiveness of Neovascular Age-related Macular Degeneration Combined Treatment
by: L. A. Golota, et al.
Published: (2025-03-01) -
Principles of anti-VEGF dosing in the treatment of neovascular age-related macular degeneration
by: I. E. Ioshin, et al.
Published: (2019-08-01)